NRXS Competitors & Alternatives
Compare Neuraxis, Inc. with similar stocks in the same industry
Biotechnology
NRXS
Main Stock$6.80
Tradestie Score
48
Market Cap
$30.70M
Revenue Growth
0.8%
Analyst Upside
+61.8%
Top Competitors
234 stocks in Biotechnology| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
ACHV
Achieve Life Sciences, Inc.
|
$6.10
|
$158.43M | - | 48 | Compare |
|
NVCT
Nuvectis Pharma, Inc. Common Stock
|
$19.31
|
$154.27M | - | 54 | Compare |
|
CLYM
Climb Bio, Inc. Common Stock
|
$12.84
|
$133.50M | - | 52 | Compare |
|
STTK
Shattuck Labs, Inc. Common Stock
|
$7.43
|
$114.01M | - | 50 | Compare |
|
ANRO
Alto Neuroscience Inc.
|
$26.78
|
$110.20M | - | 50 | Compare |
|
RLMD
Relmada Therapeutics, Inc. Common Stock
|
$5.18
|
$71.69M | - | 46 | Compare |
|
IMMX
Immix Biopharma, Inc. Common Stock
|
$8.52
|
$67.94M | - | 52 | Compare |
|
XLO
Xilio Therapeutics, Inc. Common Stock
|
$8.65
|
$43.15M | - | 54 | Compare |
|
SHFS
SHF Holdings, Inc. Class A Common Stock
|
$0.19
|
$21.61M | - | 47 | Compare |
|
ACXP
Acurx Pharmaceuticals, Inc. Common Stock
|
$1.42
|
$7.29M | - | 42 | Compare |
More NRXS Analysis
Data updated: Jul 26, 2026 | Industry: Biotechnology (SIC 3845)
234 stocks in this industry